Anticoagulation Therapy

Since 2023 we do offer Triple Anticoagulation Therapy for microcirculation and hyper-coagulation issues, but only under certain circumstances. The Triple Therapy needs constant  monitoring of the blood to minimize the risk of (brain and gut) bleeding. A physical presence of the patient at the clinic of 3-4 months is therefore necessary. The often strong side effects from toxins and pathogens being released into the blood of the patient need to be controlled with steroids and antihistamines. 

The differences between H.E.L.P. Apheresis and Triple Anticoagulation Therapy:

-  If your local GP/PCP supports you and takes on the responsibility of constantly monitoring your blood while you are administered a combination of three anticoagulant medications at once (bleeding risk), the costs are lower than H.E.L.P. and you do not need to be present at  the clinic for 3-4 months

- Patients often do suffer from constant side-effects of the Triple Therapy from toxins and pathogens being released into the blood. Steroids and antihistamines are a way to reduce them 

- H.E.L.P. Apheresis has a higher safety profile with over 30 years of scientific data behind it

-  H.E.L.P. Apheresis does not only remove the microclots from the blood but also does remove inflammation, viral spike protein, cholesterol+autoantibodies and hundreds of pathogens and furthermore it reduces the viscosity of the blood around 10% per treatment and increases the microcirculation by 20% in total.

We do only recommend Triple Anticoagulation Therapy in first 6 months after infection/onset and/or if your local GP/PCP supports and monitors  it. 

From  our clinical experience H.E.L.P. Apheresis as part of the Combination Therapy is preferable and shows better results. The individually adapted Combination Therapy often does include anticoagulation protocols.

In Triple Therapy the body needs to deal with all the toxins and pathogens released from the microclots. Through H.E.L.P. Apheresis all toxins and pathogens are taken out of the blood by the apheresis machine and it furthermore does not only get rid of the microclots but does  additionally remove inflammation proteins, viral spike protein, cholesterol+autoantibodies and hundreds of pathogens and reduces the viscosity of the blood around 10% per treatment whilst increasing the microcirculation by 20% in total. This means it has several modes of action instead of just a single mode like triple therapy.

Furthermore from our clinical experience we have often observed that when patients are taken off Triple Anticoagulation Therapy, symptoms tend to return.

The above is the reason why we prefer a combination of DAPT (Dual Anti Platelet Therapy = Dual Anticoagulation Therapy) combined with H.E.L.P. Apheresis. 

Many patients are continuously and for years on DAPT without side effects.

Latest research shows that there is more to anticoagulation therapy in viral infections and post viral syndromes than just classic anticoagulants combined:  https://www.mdpi.com/1422-0067/24/23/17039